Tigermed (300347 CH) - Meaningful Demand Recovery in 1Q24

181 Views30 Apr 2024 08:57
Broker
1Q24 revenue / attributable recurring net income accounted for 19.8%/ 18.0%, respectively, of our 2024 full-year estimates, which were largely in line with its pre-COVID average level.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 13-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
CMB International
External broker reports(aggregated public sources)
CMB International
China & Hong KongEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x